MEDS | TRxADE HEALTH, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	7.06 - 7.70
52 Week Range	3.69 - 44.56
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	18,992
Average Volume	61,782
Shares Outstanding	1,750,060
Market Cap	13,282,955
Sector	Healthcare
Industry	Medical - Pharmaceuticals
IPO Date	2014-02-06

Valuation
Profitability
Growth
Health
P/E Ratio	-0.31
Forward P/E Ratio	-11.07
EPS	-24.38
1YR Price Target	15.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	8
Country	USA
Website	MEDS

Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.

MEDS's peers: CJJD, HITI, LFLY, PETS, SSY, WBA, YI

*Chart delayed

Analyzing fundamentals for MEDS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see MEDS Fundamentals page.

Watching at MEDS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on MEDS Technicals page.